Cynata Therapeutics Limited
Cynata Therapeutics Limited (CYYNF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CYYNF · as of Jun 9, 2026
Key Statistics
Explore Cynata Therapeutics Limited Data
cyynf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
cyynf competitorsCYYNF
CBSTF
DSOL
DTCFF
MDDVF
MMIRFStock Performance
Full HistoryAbout Cynata Therapeutics Limited
Cynata Therapeutics Limited an Australian biotechnology company headquartered in Cremorne, specializes in developing and bringing to market its unique Cymerus™ mesenchymal stem cell (MSC) technology …
what is cynata therapeutics limited · cyynf stock overview · cynata therapeutics limited company profile · who is cynata therapeutics limited ceo · cyynf OTC · cynata therapeutics limited headquarters · cynata therapeutics limited business segments
About Stock Overview & Key Data
Cynata Therapeutics Limited (CYYNF) is a Healthcare company in the Biotechnology industry, listed on OTC since May 26, 2015. As of the latest trading session, CYYNF stock price is $0.15, with a market capitalization of $36.5M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2025, Cynata Therapeutics Limited reported revenue of $1.9M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cynata Therapeutics Limited (CYYNF) stock price is $0.15. The stock is traded on OTC under the ticker symbol CYYNF. The 52-week range is $0.08 – $0.22.